Deep dive · NasdaqCM: CGEN
Compugen Ltd. stock analysis
Everything behind the call on Compugen Ltd. 6 sections, ordered the way risk stacks up: survival first, quality and price in the middle, context last. The Beacon gives you the read. This is where you check the work.
The five reads
Global tapeOverseas lean0.00%
FrankfurtCW90.00%⏱
Where else this company trades. A closed venue shows its last close, marked ⏱ — not a live price. Overseas lean is the average move across the 1 overseas venue listed above, excluding the home listing — a read on overnight sentiment rather than a signal.
The bottom linestart hereAs of 2026-09-25
Chart pattern
Between the averages
The 50-day sits above the 200-day
50-day $2.46 · -3.2%
200-day $2.23 · +6.5%
200-day $2.23 · +6.5%
Earnings
In 43 days
9 Nov 2026
beat 3–4 of the last 8
cohort P(beat) 53% · n=38,466
cohort P(beat) 53% · n=38,466
Valuation
-6.5× forward
Against consensus earnings
Dividend
0.00%
A rounding error against cash — this is a capital-gains position
Risk flags
2 on watch
5 checks run, 0 clear
beta 1.68 · vol 37% ann.
worst drawdown -37%
worst drawdown -37%
New to this? Every metric carries a plain-English read beside it, and an ⓘ next to a label opens the definition. Anything unfamiliar is also defined at the foot of the page under Glossary.
In one paragraphwhat the company actually does219 chars
Compugen Ltd., a clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutics and product candidates in Israel, the United States, and Europe.
NasdaqCM · USDBiotechnology
$2.38+0.01 · +0.42%CLOSED · vol 77.7K
52-week range↑ 72% off low · ↓ 26.5% off high
$1.38now $2.38$3.24
Quote Sep 25, 2026 · 4:00 PM ET
Tape 2026-09-25
Factors 2026-09-25
Tape 2026-09-25
Factors 2026-09-25
01
Survival & solvency
and 0 of 5 forensic checks clear.
↳ Plain EnglishBefore anything else: can this company pay its bills? These blocks check the balance sheet, whether your slice of ownership is being diluted, and whether the accounting looks honest.
Piotroski F-score
F 6/8WATCH
Piotroski F-score 6 of 8. Nine pass/fail tests covering profitability, leverage and operating efficiency; seven or more is strong.
Balance sheet
Your ownership stake
Stock-based comp / revenueIN LINE
2.6%
Stock comp is the dilution pressure a buyback has to outrun. We read up to 5% of revenue as modest and above 12% as heavy — our own reading band, not a measured peer statistic.
Diluted vs basic share gapTHIN OVERHANG
0.42%
Options and awards already granted, expressed as the gap between the diluted and basic counts.
Accounting forensicsSEC filings
Red-flag x-rayGRADE D
50 / 100
0 critical · 2 watch · 0 clear of 2 scored tests
Red-flag x-ray · every check, passes included
CheckStatusValueWhat it looks for
Bankruptcy distressNAn/aAltman-Z not available · fundamentals
Earnings manipulationNAn/aBeneish-M not available · fundamentals
LeverageNAn/aLong-term debt / equity not available · fundamentals
Profitability qualityWATCHF 6/8Piotroski F-score 6 of 8 · fundamentals
Filing forensicsWATCH1 flag1 filing red flag on the latest 10-K · forensic
5 checks, 2 watch. The passes are shown because a score built from five checks means something different from one built from three.
02
Business quality
The quality blocks below render whatever the filings support; anything absent says so in place.
↳ Plain EnglishMargins tell you how much of each sales dollar the company keeps. Return on capital tells you whether reinvesting that money creates value. Both are read against what the filings support, not against a target.
12-1 momentum
+102.9%EX LAST MONTH
Return over the last year excluding the most recent month — the standard momentum factor, which drops the short-term reversal.
Profitability
Data unavailableNo parsed income statement is on file, so margins, returns on capital and cash generation cannot be computed for this name.
Growth & relative strength
Trailing return by period
1 month-13.8%
3 months+10.2%
6 months+16.7%
Year to date+53.5%
1 year+72.5%
Relative-strength rankTOP 19%
81 / 100
Where this name's 3-month return against the S&P 500 ranks across the market — a quarter's standing, not the year's.
Around earningsAug 3, 2026
P(beat next quarter)COHORT BASE RATE
53%
survivor-tilted universe (currently-listed names; large-cap-skewed coverage)
Beat rate · this nameBEAT 3–4 OF THE LAST 8
3 of 8
Its own record against consensus. 8 prints is a small sample, which is why the cohort rate above carries the probability.
Fell after a beatP(FELL | BEAT)
38%
A beat is not a plan: this share of them still closed lower on the day.
Typical earnings moveMEDIAN ABSOLUTE
±7.2%
Unsigned magnitudes from its own prints. Direction is not part of this read.
Reaction: beat vs missASYMMETRIC
0.0% / -3.4%
The average day-one move after a beat and after a miss. A miss dropping the stock further than a beat lifts it is the asymmetry worth sizing for.
Sells the newsON THE PRINT
No
No habit of selling off on a good report in the measured window.
Dividends & income
Data unavailableThis company does not pay a dividend. There is no yield, payout ratio or ex-dividend date to show, and the return case rests entirely on capital gains.
Signal
Not an income position.
No dividend is declared, so nothing here contributes to total return except the price. That is a fact about the security, not a criticism of it.
Inventory ledger
Data unavailableNo inventory detail is tagged in this company's filings. The ledger needs the XBRL inventory components, which a business without physical goods does not report.
Segments & geography
Data unavailableRevenue by segment and region is not on file for this name, so product and geographic concentration are not shown.
Pattern reliability · platform-wide cohortSnapshot · Sep 27, 2026
Sideways
HorizonHigherMedianObservations
10d47%0.0%1,479,705
21d49%0.0%695,010
63d51%+0.1%220,093
slope +0.03 over 40 bars
Spinning top
HorizonHigherMedianObservations
10d49%0.0%195,526
21d49%-0.1%92,054
63d50%0.0%29,367
small body, shadows both sides
Head and shoulders · leans bearish
HorizonHigherMedianObservations
10d49%0.0%499,633
21d51%+0.1%235,260
63d51%+0.3%74,900
head above two ≈-equal shoulders — bearish reversal
Near support · leans bullish
HorizonHigherMedianObservations
10d51%+0.1%536,115
21d53%+0.2%251,312
63d54%+0.4%78,900
testing recent support
Bollinger squeeze
HorizonHigherMedianObservations
10d43%0.0%764,373
21d45%0.0%357,385
63d47%0.0%112,620
bands at a multi-month tight — breakout pending
03-6.5× FORWARD
Price & timing
Price $2.38, -6.5× forward earnings, RSI 44.
↳ Plain EnglishA multiple is what the market charges for a dollar of this company's earnings, cash or revenue; the trend and the options tape say what the price is doing around it. Together they are the timing picture, not the quality one.
Trend
Mixed1 OF 3 AVERAGES
50-day $2.46 · 200-day $2.23. Price above both is the structural definition of an uptrend.
The setup right now
Price · 504 sessions2024-09-23 → 2026-09-25
price50-day200-day
How to read this
Up 0.42% on the session.
Follow the solid line: each point is a session close. Compare it to the 50-day average — while price stays above it the short-term trend is up, and a drop below is the first structural warning.
Momentum (RSI-14)COOL
44
030 oversold70 hot100
Where momentum sits on a 0–100 scale. Above 70 is overbought, below 30 oversold; the middle says the move has room either way.
Typical day (ATR-14)±3.6%
$0.09
The average true range — how far this stock moves on an ordinary day. It sets the scale a stop has to clear.
MACDBELOW SIGNAL
-0.02
The short-term trend against its own signal line. The sign is the read; the size is not a target.
Bollinger position17% OF RANGE
Lower band
Where price sits inside its own volatility band. The edges are where a move is stretched, not where it reverses.
20-day VWAPPRICE BELOW
$2.49
The volume-weighted average of the last month. Price above it means recent buyers are, on average, in profit.
Chandelier exitBROKEN
$2.68
A volatility-based trailing stop, set a few average ranges below the recent high.
9 Nov 2026 · in 43 daysNext earningsThe next scheduled catalyst. The forward guide usually moves the tape more than the printed number. Date as the vendor last stated it on 7 Aug; companies confirm about three weeks ahead, so it can still move.
2026-09-29 · in 2 daysJob Openings (JOLTS)A scheduled macro release. It moves this stock independently of anything the company does.
Setup & oddsNightly
Pullback riskoverstretch read
Elevated1.05× segment rate · n=504
Historically, micro names in this tape state saw a ≥10% pullback within 63 trading days in 93% of cases (n=504).
Overstretchvs the 20-day mean
-1.3σ
How many standard deviations price sits from its 20-day mean. Beyond 2σ is genuinely stretched; inside it is ordinary.
Bottom zoneif it breaks down
$2 – $23 supports
Where prior demand appeared: Pivot low at $2.37, S1 at $2.35, Pivot low at $2.30.
Slide scorefalling-knife check
78 / 100Falling knife
A composite of consecutive down days, gap risk and volume expansion. Low means any decline is orderly.
Signal
The odds lean, the stretch qualifies it.
Not enough fundamental coverage to score this name's red-flag cohort — no 12-month odds shown.
Valuation
Earnings yield vs cashABOVE CASH
11.02pp
The earnings yield clears the risk-free rate, so the current return alone competes with cash.
Multiples
Forward P/EAnalysts expect a loss over the next twelve months, so there are no earnings for the price to be a multiple of.Not meaningful
Trailing P/Eearnings already reported6.3×
0 of the 1 priced multiple above sit in the richer half of its band. 1 is marked not meaningful because the figure it divides into is negative — shown as absent rather than as a low, cheap-looking number. Each priced multiple is read against this stock's own history where a five-year range is on file, so the question is whether today is dear for this name rather than for the market. The multiples are computed separately from the quote above and are not re-priced as it moves, so they can lag it.
Price horizon & timing
Data unavailableMicro-cap names are excluded from the level composer by design. At this size the daily range routinely swallows the distance between an entry and a stop, so the levels would describe noise rather than structure.
Gamma map
Data unavailableThis name has no listed options chain, so there is no dealer gamma to map. Regime, flip level, walls and the implied move all need a chain to exist.
Options tape
Data unavailableNo options chain is connected for this ticker. Max pain, the put/call ratio, the implied move and the open-interest ladder all need the chain feed.
0413F quarterly · Form 4 dailyNET SIGNAL +3
Ownership & flow
Institutions hold 15%, short interest is 2.56% of float.
↳ Plain EnglishWho is buying and selling, and what they had to disclose. Institutions file 13F 45 days after quarter end, executives file Form 4 within two days, and Congress discloses under the STOCK Act with a 30–45 day legal lag. Every one of those is a look backwards.
Net signal
+3LEANING · 30d
1 bull / 0 bear factors. The points sum to the net beside the label; nothing here is weighted after the fact.
The QTick signalNightly
Earnings4 QUARTERS · TIMING
+3
latest EPS beat by 18%
Signal
1 bull / 0 bear factors
Independent factors scored and netted to +3 over 30d, a leaning reading. 1 of 9 factors carried a direction; the others scored zero and do not vote. The signal describes where the data leans, not what to do about it.
Cross-category read
Data unavailableFewer independent evidence families are ready than the engine's minimum, so there is nothing to check for agreement. A cross-category read over two categories is not a read.
Wall Street
Data unavailableNo sell-side firm publishes research on this name. There is no consensus rating, no price target and no estimate revisions to weigh — for a company this size that is the norm rather than a gap in our data.
Who owns it13F quarterly · Form 4 daily
Institutional ownershipRETAIL-HEAVY
15.2%
The share held by 13F filers. It describes last quarter's positioning, not today's — filings land up to 45 days after quarter end.
Insider ownershipOFFICERS & DIRECTORS
2.1%
The share held by the people running the company.
Short interest (float)LIGHT
2.56%
Falling — shares short changed -21.9% over 30 days. There is no short base to squeeze here.
Free float98% OF SHARES
92.42M
Shares actually available to trade, excluding insider and restricted holdings.
Dollar volume (ADV)38th PCTILE
$637,583/day
Average dollars traded per day, and where that ranks cross-sectionally. Thin liquidity is a cost you pay on the way out, not just on the way in.
Borrow feeData unavailableWe do not license securities-lending data, so the annualized cost of borrowing shares to short is not something we can show. Short interest and days-to-cover above are the closest read we can source.
The story · news & sentimentRolling window
Why it moved todayNONE
+0.42%
CGEN was little changed +0.42% since the last close — no notable catalyst, and the move itself was modest.
Congress
Data unavailableNo congressional trades in this name have been disclosed under the STOCK Act. Lawmakers' disclosed trades cluster heavily in large caps, so an empty list is the usual state.
050 graded callsORDINARY VOLATILITY
Risk & track record
Beta 1.68, 37% annual volatility, a -37% worst drawdown, and 3 of 8 risk surfaces clear.
↳ Plain EnglishWhat owning it does to a portfolio, what the model votes against, and how often our own calls have been right. Every call is graded when it resolves, and the ones still open stay visible.
Max drawdown
-36.8%WORST FALL
The deepest peak-to-trough fall in the measured window. Only hold a position you can watch do this.
What it does to a portfolio5-year window
Beta (vs the market)LOW FIT
1.68
The market explains about 9.7% of its daily moves, so this beta says little about how it tracks the index — most of its movement is its own.
Annualized volatilityORDINARY
37%
How far it swings over a year, from its own realized returns.
Tactical phaseNIGHTLY READ
Falling knife
Selling pressure52
Buying pressure0
Overheat0
State: falling_knife — Still breaking lower without consolidation — a fresh swing-low printed and no basing pattern has formed yet.
What votes against
Data unavailableNo factor in the model currently votes against this name. That is a statement about the model's inputs today, not a claim that nothing could go wrong.
Failure modes · by company type
Data unavailableFailure modes are routed per company type, and only the bank-run and crypto-treasury rulebooks are validated so far. This name routes as unknown, so there is no cohort-specific checklist to run. A generic list would read as analysis without being any.
The risk case · why not to buy8 surfaces · nightly
Suggested position capmax defensible size
1.9%tail cap binds
max defensible size 1.9% - tail binds
Avoid score6-month distress
18.6%1.3× its cohort · $1–$5 names
Observational 6-month large-drawdown risk ranking — not a forecast, not alpha. Historical distress rate for this $1–$5 names segment: 14.8%. This name reads 1.3× that base rate.
LowDistress screenThe distress model did not score this name in the latest run, so this surface is unmeasured rather than clear.Not scored
MedPosition size, not conviction, is the binding constrainthalf-Kelly 22.0% · tail cap 1.9% · category cap 13.7%. The tail cap binds, so 1.9% is the number (n=75,992). We show which one binds rather than the friendliest.Sizing
LowLottery-ticket behaviourIts best 21-day return sits at 2.1% against a 23.4% cohort 90th-percentile threshold — below the line where forward returns have historically turned negative.Behaviour
LowCash runwayNot scored for this name.Not scored
LowPost-earnings driftDrift odds at full strength (+3.21% / 63-day spread reference from measured post-earnings drift).Timing
LowDividend riskNot scored for this name.Not scored
LowRestatement historyFiling history is not deep enough to check for restatements.Not scored
LowCrowded shortNot in a warn state: the crowded-short model only publishes when short interest and thin liquidity coincide, and neither condition is met here.Not scored
Signal
3 of 8 surfaces clear.
8 surfaces checked, 3 clear. The binding constraint is position size — the tail cap is the one that binds. Each row states which surface it is and what it measured; a surface that could not be scored says so rather than counting as clear.
Who should skip it
Skip it if any of these is you
You can't sit through -37%
That is this name's deepest measured fall, on 37% annualized volatility. A drawdown of that size is normal here, not exceptional.
You want income
A 0.00% yield is a rounding error against cash. This is a capital-gains position.
You're already heavy in this market
A 1.68 beta means you would be stacking the same bet rather than spreading it.
You'd size it like a core holding
The binding cap is 1.9% of a portfolio. Above that the tail stops being survivable.
Our track record0 resolved
Track recordBUILDING IN THE OPEN
10 logged
10 calls logged on this name, 0 resolved so far. Calls are logged the moment they are made, so the open ones are public before anyone knows how they turn out, and a hit-rate is not published until enough of them resolve.
Calls on CGENTHIS NAME
10
This name's own call count. Too few have resolved to publish a rate over them, so none is shown rather than a rate over 0.
0610-K disclosed linksBIOTECHNOLOGY
The wider context
5 mapped peers, 3 connections.
↳ Plain EnglishCompanies do not trade alone. This is the peer set, the supply chain that has to deliver, and the macro variables that move the stock regardless of company news.
Rate sensitivity
+15.9% per +1ppINSUFFICIENT
This is the SECTOR prior, not a measurement of this name — the regression did not clear its own bar. The verdict beside it (neutral) comes from the prior too, so the two agree by construction rather than by evidence.
Versus peersLatest session
Peer set · 5 names
SymbolRelationshipPriceSession
VRTXPeer$526.19+0.73%
REGNPeer$788.04-1.00%
ARGXPeer$959.49-0.28%
RVMDPeer$204.97+2.56%
ALNYPeer$255.96+2.55%
The mapped peer set and how each traded in the latest session. A peer moving with this name says the move is the sector's; one moving against it says the move is this company's.
Time machineHistory from 2023-06-01
Signal
Every backward window is positive.
That is the definition of a stock that has already worked, and it says nothing about the next window. What it does tell you is what a drawdown would be measured against.
Macro driversRolling window
Next macro catalystIN 2 DAYS
Job Openings (JOLTS)
2026-09-29. A scheduled release that moves this stock independently of anything the company does.
Events · what moves this stockSep 25, 2026
Initial jobless claimsLittle effect either way
Healthcare demand does not depend on hiring.
Typical for the Healthcare sector
On the day -0.1% · A week later +1.0% · Two weeks later +2.2% · Rose on 76 of 170 report days
Across the last 170 Initial jobless claims reports since Jun 8, 2023, CGEN moved -0.1% on average on the day and was 2.2% higher two weeks later. The S&P 500 moved 0.0% on those days.
Core PCE (the Fed's gauge) is due in 3 days.
Core PCE (the Fed's gauge)Little effect either wayPeople need care regardless of prices; healthcare barely reacts to the print itself.
Typical for the Healthcare sector
On the day +0.2% · A week later -0.3% · Two weeks later +1.9% · Rose on 16 of 39 report days
Across the last 39 Core PCE (the Fed's gauge) reports since Jun 28, 2023, CGEN moved +0.2% on average on the day and was 1.9% higher two weeks later. The S&P 500 moved +0.2% on those days.
FOMC decisionLittle effect either way
Healthcare demand does not depend on rates.
Typical for the Healthcare sector
On the day +0.4% · A week later -0.2% · Two weeks later +1.0% · Rose on 21 of 39 report days
Across the last 39 FOMC decision reports since Jul 1, 2023, CGEN moved +0.4% on average on the day and was 1.0% higher two weeks later. The S&P 500 moved -0.1% on those days.
On the day -0.1% · A week later +1.3% · Two weeks later +1.0% · Rose on 12 of 39 report days
Across the last 39 Housing starts reports since Jun 20, 2023, CGEN moved -0.1% on average on the day and was 1.0% higher two weeks later. The S&P 500 moved 0.0% on those days.
Industrial productionLittle effect either way
Healthcare does not track the business cycle.
Typical for the Healthcare sector
On the day -0.2% · A week later +1.6% · Two weeks later +2.9% · Rose on 18 of 39 report days
Across the last 39 Industrial production reports since Jun 15, 2023, CGEN moved -0.2% on average on the day and was 2.9% higher two weeks later. The S&P 500 moved +0.1% on those days.
Job openings (JOLTS) is due in 2 days.
Job openings (JOLTS)Little effect either wayHealthcare demand does not depend on hiring.
Typical for the Healthcare sector
On the day -0.9% · A week later +1.0% · Two weeks later +4.2% · Rose on 13 of 39 report days
Across the last 39 Job openings (JOLTS) reports since Jul 5, 2023, CGEN moved -0.9% on average on the day and was 4.2% higher two weeks later. The S&P 500 moved 0.0% on those days.
Jobs report (nonfarm payrolls) is due in 5 days.
Jobs report (nonfarm payrolls)Little effect either wayHealthcare demand does not depend on hiring.
Typical for the Healthcare sector
On the day -0.6% · A week later +1.5% · Two weeks later +3.5% · Rose on 14 of 39 report days
Across the last 39 Jobs report (nonfarm payrolls) reports since Jul 6, 2023, CGEN moved -0.6% on average on the day and was 3.5% higher two weeks later. The S&P 500 moved -0.1% on those days.
PCE inflation is due in 3 days.
PCE inflationLittle effect either wayPeople need care regardless of prices; healthcare barely reacts to the print itself.
Typical for the Healthcare sector
On the day +0.2% · A week later -0.3% · Two weeks later +1.9% · Rose on 16 of 39 report days
Across the last 39 PCE inflation reports since Jun 28, 2023, CGEN moved +0.2% on average on the day and was 1.9% higher two weeks later. The S&P 500 moved +0.2% on those days.
Customer momentum
Data unavailableCustomer momentum needs listed customers that disclose a revenue dependence on this company, and none is on file. The connections below are a different map: competitors and partners, most of them curated rather than filed.
Connections3 links · none confirmed
Direct connections · 3 edges
CompanyRelationSessionProvenance
IQV · Partnerpartner-1.69%Rumored · manual
AMZN · Suppliersupplier+0.12%Rumored · manual
PFE · Competitorcompetitor+0.92%Rumored · manual
0 of 3 edges are named in a filing; the rest come from reporting we have not matched to one yet, and are labelled as such.
Glossary · every term on this page
Survival
Altman Z
Bankruptcy-risk score. Above 3.0 is the safe band.
Piotroski F
Nine pass/fail health tests; 7 or more is strong.
Beneish M
Accrual and growth pattern screen. Clear below −2.22, watch to −1.78, elevated above; a year of very fast revenue growth lifts it by construction.
Merton DTD
Standard deviations of asset value between the company and its debt.
EDF
Default frequency calibrated on what actually happened to similar names.
Price & tape
RSI-14
Momentum gauge 0–100. Above 70 is overbought, below 30 oversold.
ATR
Average true range — the size of a typical day.
VWAP
20-day volume-weighted average price — the average paid over the last month; the page shows no intraday VWAP.
Supertrend
A trend-following stop line. A close through it flips the read.
Chandelier
A trailing stop set a few average ranges below the recent high.
Options & flow
Gamma / GEX
Dealer hedging pressure. Negative gamma amplifies moves both ways.
Call / put wall
The strikes with the heaviest open interest; they act as ceiling and floor.
Max pain
The strike where most options expire worthless.
13F · Form 4
Institutional filings, 45 days after quarter end. Insider trades, within two days.
Scoring
Composite signal
Independent factors scored and netted into one number.
Hit-rate
Share of past calls that resolved in the direction stated.
Brier score
Calibration measure. Lower means stated probabilities track reality.
HHI
Concentration 0–10,000. Above 2,500 means one segment carries the company.
EVT
Fits the tail rather than assuming a bell curve, so bad days are not understated.